The Hidden Burden: Depression’s Impact on Adults with Epilepsy

For adults living with epilepsy, the challenges extend beyond managing seizures. A significant, often overlooked, comorbidity is depression, affecting an estimated 23% of individuals with the neurological condition. This connection isn’t simply a reaction to living with epilepsy; depressive symptoms can even precede a diagnosis, suggesting shared underlying brain changes.

Dr. Rosa Michaelis, a neurologist and psychotherapist at a level four epilepsy centre in Germany, emphasizes the importance of recognizing this connection. “Depression is very common and we need to keep this in mind for every person with epilepsy, regardless of their age or specific diagnosis,” she stated. The impact is far-reaching, influencing medication adherence, seizure control and even the risk of developing drug-resistant epilepsy.

Understanding the Complex Relationship

The interplay between epilepsy and depression is multifaceted. It’s a complex web involving brain networks, neurotransmitters, seizure activity, anti-seizure medications, and individual lived experiences. This complexity highlights the need for a holistic approach to care, acknowledging that depression isn’t merely a byproduct of seizures but an independent factor impacting quality of life.

Even individuals experiencing well-controlled seizures can experience a significantly lower quality of life if they are also battling depression. This underscores the importance of addressing mental health alongside neurological symptoms. The risk of mortality, particularly through suicidality, is demonstrably increased in people with epilepsy, especially those with a history of depression, frequent seizures, or recently diagnosed conditions.

Did You Know? People with temporal lobe epilepsy tend to have a higher risk of experiencing depression.

Diagnosis and Treatment Approaches

Early and systematic screening is crucial. Dr. Michaelis recommends utilizing the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), a quick six-question tool that screens for both depression and suicidality. A key question on the NDDI-E – “I’d be better off dead” – warrants further exploration, as asking about suicidal thoughts does not increase risk and can open a vital dialogue.

Treatment approaches vary based on severity. For mild to moderate depression, shared decision-making between patient and clinician determines whether to pursue psychotherapy or antidepressant medication, with SSRIs being a first-line choice due to their minimal impact on seizure activity. Cognitive Behavioral Therapy (CBT) has also proven effective. Severe depression typically requires a combination of both antidepressants and psychotherapy.

Expert Insight: Recognizing the shortage of mental health professionals, neurologists have a critical role to play in initiating treatment and building integrated care pathways to ensure patients receive timely and appropriate support.

Access to care can be a barrier, particularly for those with driving restrictions. Online therapy options, both guided and unguided, offer a valuable solution. It’s also essential to consider the potential psychotropic side effects of anti-seizure medications and adjust treatment plans accordingly.

Beyond Medical Intervention

Lifestyle factors play a significant role in managing depression. Regular exercise, consistent sleep, and a balanced diet are universally beneficial, and may even contribute to better seizure control. Social support is also protective, reducing both depressive symptoms and seizure-related disability.

However, initiating these changes can be challenging when already struggling with depression. Motivational interviewing, focusing on eliciting existing strengths and joys, can be a more effective approach than simply prescribing a list of “shoulds.”

What Might Happen Next

As awareness of the link between epilepsy and depression grows, it is likely that more integrated care models will emerge, bringing mental health services closer to neurological care. Clinicians may increasingly adopt routine depression screening as a standard part of epilepsy management. Further research could also lead to a better understanding of the underlying neurological mechanisms connecting the two conditions, potentially paving the way for more targeted treatments.

Frequently Asked Questions

What percentage of adults with epilepsy experience depression? Approximately 23% of adults with epilepsy experience depression at any given point in time.

What is the NDDI-E? The NDDI-E (Neurological Disorders Depression Inventory for Epilepsy) is a six-question screening tool used to identify both depression and suicidality in people with epilepsy.

Can anti-seizure medications contribute to depression? Yes, some anti-seizure medications, like topiramate and zonisamide, can increase the risk of depressive symptoms. Conversely, others, like lamotrigine or gabapentin, may have mood-stabilizing properties.

How can we better support individuals navigating the complexities of both epilepsy and depression?